[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Markets Direct: Market Research Reports

Global Markets Direct is a cutting-edge provider of market research and business consultancies for a wide range of customers worldwide.

A team of analytics is capable to produce all sorts of market information and carry out extensive industry research using unique data and reliable sources to let customers know who they are at the market. Global Markets Direct has profound analytical experience in researching the industries and preparing customized reports across many specific fields.

The company is distinguished by its high-quality consulting products and close inspection of the issues under study. Diligent efforts of the experts make every piece of business information an exclusive source of feasible solutions and valuable advice.

With a commitment to serve every client need, Global Markets Direct collects and interprets the materials for the analysis, uses methods of primary and secondary research and develops one of a kind data packages for global clients. They are able to cover the tones of industry-related information to assist customers in taking the right business decisions and developing their strategic plans.

Under the supervision of skillful managers and experts, business analysts produce reports that include:

  • Product portfolio
  • Potentially strong market reviews
  • Competitive analytics
  • Prospect partners
  • Mergers and acquisitions project data
  • Latest trends across a particular industry area
  • Research and development strategies
  • The analysis of new customers
  • A set of remedial measures for projects

They will search for new partners and highlight the current business issues plus develop new strategies and tactical steps to help you take the lead in the industry where you operate.

Publications found: 5,853
Sort by:

Metabolic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metabolic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metabolic Syndrome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Pl...

May 2022 58 pages

Metastatic Adenocarcinoma of The Pancreas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Adenocarcinoma of The Pancreas Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Adenocarcinoma of The Pancreas Drugs in Development by Stag...

May 2022 120 pages

Metastatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Bile Duct Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecu...

May 2022 38 pages

Metastatic Biliary Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Biliary Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Biliary Tract Cancer Drugs in Development by Stages, Target, MoA, RoA...

May 2022 97 pages

Metastatic Hepatocellular Carcinoma (HCC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Hepatocellular Carcinoma (HCC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Hepatocellular Carcinoma (HCC) Drugs in Development by Stag...

May 2022 109 pages

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Metastatic Hormone Refractory (Castration Resistant, Androgen-Independent) Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Hormone Re...

May 2022 292 pages

Metastatic Liver Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Liver Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Liver Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type...

May 2022 60 pages

Metastatic Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Ovarian Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 100 pages

Metastatic Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Metastatic Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Pancreatic Cancer Drugs in Development by Stages, Target, MoA, RoA, Mole...

May 2022 231 pages

Metastatic Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Prostate Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 84 pages

Metastatic Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Metastatic Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Renal Cell Carcinoma Drugs in Development by Stages, Target, MoA, RoA...

May 2022 133 pages

Metastatic Transitional (Urothelial) Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Transitional (Urothelial) Tract Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Transitional (Urothelial) Tract Cancer Drugs in Dev...

May 2022 120 pages

Metastatic Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Metastatic Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Metastatic Uveal Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule T...

May 2022 64 pages

Methyl CpG Binding Protein 2 (MECP2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Methyl CpG Binding Protein 2 (MECP2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Methyl CpG Binding Protein 2 (MECP2) Drugs in Develo...

May 2022 39 pages

Methylmalonic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Methylmalonic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Methylmalonic Acidemia Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 41 pages

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Methylmalonyl CoA Mutase Mitochondrial (Methylmalonyl CoA Isomerase or MCM or MUT or EC 5.4.99.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players...

May 2022 35 pages

microRNA 21 (MIR21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

microRNA 21 (MIR21) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY microRNA 21 (MIR21) Drugs in Development by Therapy Areas and Indicat...

May 2022 37 pages

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Microtubule Associated Protein Tau (Neurofibrillary Tangle Protein or Paired Helical Filament Tau or MAPT) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Ke...

May 2022 120 pages

Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Middle East Respiratory Syndrome coronavirus S Protein (Spike Protein) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Middle East Respir...

May 2022 45 pages

Mitochondrial Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mitochondrial Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mitochondrial Diseases Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 53 pages

Mitochondrial Myopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mitochondrial Myopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mitochondrial Myopathy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type an...

May 2022 42 pages

Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine-Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mitogen Activated Protein Kinase Kinase Kinase 14 (NF Kappa Beta Inducing Kinase or Serine-Threonine Protein Kinase NIK or MAP3K14 or EC 2.7.11.25) Drugs in Development by Therapy Areas and Indication...

May 2022 35 pages

Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK-ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mitogen Activated Protein Kinase Kinase Kinase Kinase 1 (Hematopoietic Progenitor Kinase or MAPK-ERK Kinase Kinase Kinase 1 or HPK1 or MAP4K1 or EC 2.7.11.1) Drugs in Development by Therapy Areas and...

May 2022 50 pages

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mitogen Activated Protein Kinase Kinase (MEK or MAP2K or EC 2.7.12.2) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Mitogen Activated P...

May 2022 73 pages

Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mitogen Activated Protein Kinase (MAPK or EC 2.7.11.24) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Mitogen Activated Protein Kinase...

May 2022 98 pages

Molluscum Contagiosum Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Molluscum Contagiosum Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Molluscum Contagiosum Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 37 pages

Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Monoamine Oxidase (Adrenalin Oxidase or Epinephrine Oxidase or MAO or EC 1.4.3.4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Monoami...

May 2022 64 pages

Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Monocarboxylate Transporter 1 (MCT 1 or Solute Carrier Family 16 Member 1 or SLC16A1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Mon...

May 2022 36 pages

Mouth and Dental Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mouth and Dental Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mouth and Dental Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule...

May 2022 103 pages

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 3,500.00

Mu Type Opioid Receptor (MOR1 or Mu Opiate Receptor or Mu Opioid Receptor or OPRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Mu Ty...

May 2022 224 pages

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) Drugs...

May 2022 35 pages

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy Syndrome ) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mucopolysaccharidosis VI (MPS VI) (Maroteaux-Lamy S...

May 2022 37 pages

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Multiple Organ Failure (Multiple Organ Dysfunction Syndrome) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Multiple Organ Failure (Multiple Organ Dysfunction...

May 2022 38 pages

Muscarinic Acetylcholine Receptor M1 (CHRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Muscarinic Acetylcholine Receptor M1 (CHRM1) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Muscarinic Acetylcholine Receptor M1 (CHRM1)...

May 2022 64 pages

Muscarinic Acetylcholine Receptor M3 (CHRM3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Muscarinic Acetylcholine Receptor M3 (CHRM3) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Muscarinic Acetylcholine Receptor M3 (CHRM3)...

May 2022 57 pages

Muscle Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players pr...

May 2022 40 pages

Muscle Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Injury Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 39 pages

Muscle Invasive Bladder Cancer (MIBC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Invasive Bladder Cancer (MIBC) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Invasive Bladder Cancer (MIBC) Drugs in Development by Stages, Targ...

May 2022 72 pages

Muscle Spasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Spasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Spasm Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players provid...

May 2022 35 pages

Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Spasticity Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 64 pages

Muscle Wasting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Muscle Wasting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Muscle Wasting Disorders Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 57 pages

Musculoskeletal Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Musculoskeletal Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Musculoskeletal Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Ke...

May 2022 107 pages

Myalgia (Muscle Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myalgia (Muscle Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myalgia (Muscle Pain) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and...

May 2022 37 pages

Mycobacterium avium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mycobacterium avium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mycobacterium avium Infections Drugs in Development by Stages, Target, MoA, RoA,...

May 2022 42 pages

Mycobacterium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mycobacterium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mycobacterium Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Typ...

May 2022 298 pages

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mycobacterium tuberculosis ESAT 6 Protein EsxA (6 kDa Early Secretory Antigenic Target or esxA) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players S...

May 2022 35 pages

Mycobacterium Tuberculosis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mycobacterium Tuberculosis Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mycobacterium Tuberculosis Infections Drugs in Development by Stages, Targ...

May 2022 267 pages

Mycobacterium tuberculosis Protein Ag85A Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players

US$ 2,500.00

Mycobacterium tuberculosis Protein Ag85A Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players SUMMARY Mycobacterium tuberculosis Protein Ag85A Drugs i...

May 2022 36 pages

Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Mycosis Fungoides Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Play...

May 2022 70 pages

Myelofibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players

US$ 2,000.00

Myelofibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players SUMMARY Myelofibrosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players prov...

May 2022 113 pages

Filters

Search

Categories

2,264
2,910
126
9
6
1
1
1
4
522
3
6

Publishers

5,853

Regions

5,853

Price

Date

Pages

Offers